Atopic Dermatitis:グローバル臨床試験レビューH1, 2013...市場調査レポートについてご紹介

【英文タイトル】Atopic Dermatitis Global Clinical Trials Review, H1, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Atopic Dermatitis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Atopic Dermatitis 24
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Atopic Dermatitis Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Astellas Pharma Inc. 31
Clinical Trial Overview of Astellas Pharma Inc. 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Maruho Co., Ltd. 34
Clinical Trial Overview of Maruho Co., Ltd. 34
LEO Pharma A/S 35
Clinical Trial Overview of LEO Pharma A/S 35
Laboratoires Pierre Fabre SA 36
Clinical Trial Overview of Laboratoires Pierre Fabre SA 36
Galderma S.A. 37
Clinical Trial Overview of Galderma S.A. 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Fougera Pharmaceuticals Inc. 39
Clinical Trial Overview of Fougera Pharmaceuticals Inc. 39
Shionogi & Co., Ltd. 40
Clinical Trial Overview of Shionogi & Co., Ltd. 40
Regeneron Pharmaceuticals, Inc. 41
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 41
MIKA Pharma GmbH 42
Clinical Trial Overview of MIKA Pharma GmbH 42
Anacor Pharmaceuticals, Inc. 43
Clinical Trial Overview of Anacor Pharmaceuticals, Inc. 43
Intendis GmbH 44
Clinical Trial Overview of Intendis GmbH 44
Derm Research, PLLC 45
Clinical Trial Overview of Derm Research, PLLC 45
ALK-Abello A/S 46
Clinical Trial Overview of ALK-Abello A/S 46
Kaken Pharmaceutical Co., Ltd. 47
Clinical Trial Overview of Kaken Pharmaceutical Co., Ltd. 47
Bayer AG 48
Clinical Trial Overview of Bayer AG 48
Max Zeller Sohne AG 49
Clinical Trial Overview of Max Zeller Sohne AG 49
Orion Oyj 50
Clinical Trial Overview of Orion Oyj 50
Chugai Pharmaceutical Co., Ltd. 51
Clinical Trial Overview of Chugai Pharmaceutical Co., Ltd. 51
Clinical Trial Overview of Top Universities / Institutes / Hospitals 52
Wake Forest University 52
Clinical Trial Overview of Wake Forest University 52
Dresden University of Technology 53
Clinical Trial Overview of Dresden University of Technology 53
Oregon Health and Science University 54
Clinical Trial Overview of Oregon Health and Science University 54
University of California, Davis 55
Clinical Trial Overview of University of California, Davis 55
Hadassah Medical Organization 56
Clinical Trial Overview of Hadassah Medical Organization 56
Helsinki University Central Hospital 57
Clinical Trial Overview of Helsinki University Central Hospital 57
The Royal Children’s Hospital 58
Clinical Trial Overview of The Royal Children’s Hospital 58
Yokohama City University 59
Clinical Trial Overview of Yokohama City University 59
Children’s Clinic Randers 60
Clinical Trial Overview of Children’s Clinic Randers 60
Assistance Publique Hopitaux De Marseille 61
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 61
FUDAN University 62
Clinical Trial Overview of FUDAN University 62
Medical College of Wisconsin 63
Clinical Trial Overview of Medical College of Wisconsin 63
Tufts Medical Center 64
Clinical Trial Overview of Tufts Medical Center 64
Northwestern University 65
Clinical Trial Overview of Northwestern University 65
VU University Medical Center 66
Clinical Trial Overview of VU University Medical Center 66
Rockefeller University 67
Clinical Trial Overview of Rockefeller University 67
Kyoto University 68
Clinical Trial Overview of Kyoto University 68
University of Missouri 69
Clinical Trial Overview of University of Missouri 69
University of Michigan 70
Clinical Trial Overview of University of Michigan 70
UMC Utrecht Holding BV 71
Clinical Trial Overview of UMC Utrecht Holding BV 71
Five Key Clinical Profiles 72
Appendix 89
Abbreviations 89
Definitions 89
Research Methodology 90
Secondary Research 90
About GlobalData 91
Contact Us 91
Disclaimer 91
Source 92


【レポート販売概要】

■ タイトル:Atopic Dermatitis:グローバル臨床試験レビューH1, 2013
■ 英文:Atopic Dermatitis Global Clinical Trials Review, H1, 2013
■ 発行日:2013年1月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160209
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。